Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (201-210 of 752) with videos related to

Pageof 76
Sort By:
Critical Care Medicine|September 28, 2002
Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6Alexander Geppert, Angela Steiner, Gerlinde Zorn, et al.
Platelets|August 8, 2019
The association of P2Y<sub>12</sub> inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery diseasePaul M Haller, Stefan Stojkovic, Edita Piackova, et al.
The American Journal of Cardiology|February 28, 2002
Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarctionRonald Hödl, Kurt Huber, Wilfried Kraxner, et al.
European Heart Journal. Acute Cardiovascular Care|June 4, 2016
Editor's Choice-Rule-in of acute myocardial infarction: Focus on troponinMartin Möckel, Evangelos Giannitsis, Christian Mueller, et al.
European Heart Journal. Acute Cardiovascular Care|July 11, 2014
In search for the Holy Grail: suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care AssociationAllan S Jaffe, Martin Moeckel, Evangelos Giannitsis, et al.
European Heart Journal. Acute Cardiovascular Care|January 14, 2016
Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?Johannes Mair, Bertil Lindahl, Evangelos Giannitsis, et al.
Journal of Clinical Lipidology|December 22, 2015
Premature myocardial infarction is strongly associated with increased levels of remnant cholesterolGeorg Goliasch, Franz Wiesbauer, Hermann Blessberger, et al.
Thrombosis and Haemostasis|January 12, 2012
Contemporary use of glycoprotein IIb/IIIa inhibitorsSteen Dalby Kristensen, Morten Würtz, Erik Lerkevang Grove, et al.
Biochemical Pharmacology|March 17, 2006
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitroSvitlana Demyanets, Christoph Kaun, Stefan Pfaffenberger, et al.
European Heart Journal. Acute Cardiovascular Care|July 3, 2016
Rapid rule out of acute myocardial infarction: novel biomarker-based strategiesChristian Mueller, Evangelos Giannitsis, Martin Möckel, et al.
Pageof 76

Showing results (201-210 of 752) with videos related to

Sort By:
Pageof 76
Critical Care Medicine|September 28, 2002
Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6Alexander Geppert, Angela Steiner, Gerlinde Zorn, et al.
Platelets|August 8, 2019
The association of P2Y<sub>12</sub> inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery diseasePaul M Haller, Stefan Stojkovic, Edita Piackova, et al.
The American Journal of Cardiology|February 28, 2002
Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarctionRonald Hödl, Kurt Huber, Wilfried Kraxner, et al.
European Heart Journal. Acute Cardiovascular Care|June 4, 2016
Editor's Choice-Rule-in of acute myocardial infarction: Focus on troponinMartin Möckel, Evangelos Giannitsis, Christian Mueller, et al.
European Heart Journal. Acute Cardiovascular Care|July 11, 2014
In search for the Holy Grail: suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care AssociationAllan S Jaffe, Martin Moeckel, Evangelos Giannitsis, et al.
European Heart Journal. Acute Cardiovascular Care|January 14, 2016
Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?Johannes Mair, Bertil Lindahl, Evangelos Giannitsis, et al.
Journal of Clinical Lipidology|December 22, 2015
Premature myocardial infarction is strongly associated with increased levels of remnant cholesterolGeorg Goliasch, Franz Wiesbauer, Hermann Blessberger, et al.
Thrombosis and Haemostasis|January 12, 2012
Contemporary use of glycoprotein IIb/IIIa inhibitorsSteen Dalby Kristensen, Morten Würtz, Erik Lerkevang Grove, et al.
Biochemical Pharmacology|March 17, 2006
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitroSvitlana Demyanets, Christoph Kaun, Stefan Pfaffenberger, et al.
European Heart Journal. Acute Cardiovascular Care|July 3, 2016
Rapid rule out of acute myocardial infarction: novel biomarker-based strategiesChristian Mueller, Evangelos Giannitsis, Martin Möckel, et al.
Pageof 76